Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Dispenzieri

Showing results (681-690 of 759) with videos related to

Pageof 76
Sort By:
Blood Cancer Journal|June 14, 2018
Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteriaArjun Lakshman, S Vincent Rajkumar, Francis K Buadi, et al.
Blood Cancer Journal|February 27, 2020
Blood mass spectrometry detects residual disease better than standard techniques in light-chain amyloidosisAngela Dispenzieri, Bonnie Arendt, Surendra Dasari, et al.
British Journal of Haematology|August 9, 2017
Dexamethasone, rituximab and cyclophosphamide for relapsed and/or refractory and treatment-naïve patients with Waldenstrom macroglobulinemiaJonas Paludo, Jithma P Abeykoon, Shaji Kumar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 7, 2025
New Validated Staging System for Light Chain (AL) Amyloidosis With Stage IIIC Defining Ultra-Poor Risk: AL International Staging SystemJahanzaib Khwaja, Amy A Kirkwood, Paolo Milani, et al.
JACC. Cardiooncology|April 22, 2026
Cardiac Biomarker Complete Response in AL Amyloidosis: Characteristics, Cardiac Recovery, and Survival of 63 PatientsEli Muchtar, Susan Geyer, Angela Dispenzieri, et al.
Blood|January 24, 2004
Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: a case-control studyAngela Dispenzieri, Robert A Kyle, Martha Q Lacy, et al.
Blood|June 22, 2011
Trends in allogeneic stem cell transplantation for multiple myeloma: a CIBMTR analysisShaji Kumar, Mei-Jie Zhang, Peigang Li, et al.
Blood Cancer Journal|January 9, 2020
Long-term outcomes of IMiD-based trials in patients with immunoglobulin light-chain amyloidosis: a pooled analysisRahma Warsame, Betsy LaPlant, Shaji K Kumar, et al.
American Journal of Hematology|March 5, 2020
Utilizing multiparametric flow cytometry in the diagnosis of patients with primary plasma cell leukemiaLaura A Evans, Dragan Jevremovic, Bharat Nandakumar, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 27, 2021
Kidney Transplantation in Patients With Monoclonal Gammopathy of Renal Significance (MGRS)-Associated Lesions: A Case SeriesCihan Heybeli, Mariam Priya Alexander, Andrew J Bentall, et al.
Pageof 76

Showing results (681-690 of 759) with videos related to

Sort By:
Pageof 76
Blood Cancer Journal|June 14, 2018
Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteriaArjun Lakshman, S Vincent Rajkumar, Francis K Buadi, et al.
Blood Cancer Journal|February 27, 2020
Blood mass spectrometry detects residual disease better than standard techniques in light-chain amyloidosisAngela Dispenzieri, Bonnie Arendt, Surendra Dasari, et al.
British Journal of Haematology|August 9, 2017
Dexamethasone, rituximab and cyclophosphamide for relapsed and/or refractory and treatment-naïve patients with Waldenstrom macroglobulinemiaJonas Paludo, Jithma P Abeykoon, Shaji Kumar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 7, 2025
New Validated Staging System for Light Chain (AL) Amyloidosis With Stage IIIC Defining Ultra-Poor Risk: AL International Staging SystemJahanzaib Khwaja, Amy A Kirkwood, Paolo Milani, et al.
JACC. Cardiooncology|April 22, 2026
Cardiac Biomarker Complete Response in AL Amyloidosis: Characteristics, Cardiac Recovery, and Survival of 63 PatientsEli Muchtar, Susan Geyer, Angela Dispenzieri, et al.
Blood|January 24, 2004
Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: a case-control studyAngela Dispenzieri, Robert A Kyle, Martha Q Lacy, et al.
Blood|June 22, 2011
Trends in allogeneic stem cell transplantation for multiple myeloma: a CIBMTR analysisShaji Kumar, Mei-Jie Zhang, Peigang Li, et al.
Blood Cancer Journal|January 9, 2020
Long-term outcomes of IMiD-based trials in patients with immunoglobulin light-chain amyloidosis: a pooled analysisRahma Warsame, Betsy LaPlant, Shaji K Kumar, et al.
American Journal of Hematology|March 5, 2020
Utilizing multiparametric flow cytometry in the diagnosis of patients with primary plasma cell leukemiaLaura A Evans, Dragan Jevremovic, Bharat Nandakumar, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 27, 2021
Kidney Transplantation in Patients With Monoclonal Gammopathy of Renal Significance (MGRS)-Associated Lesions: A Case SeriesCihan Heybeli, Mariam Priya Alexander, Andrew J Bentall, et al.
Pageof 76